arBtrage CAPITALIZING MARKETS checking… Sign in

NRX Pharmaceuticals, Inc.

NRXP Health Care Biotechnology: Pharmaceutical Preparations
$4.14
▲ +2.2% Today
as of Jun 7, 07:22 ET
Last 30 days +40.34% Apr 28 → Jun 05
$2.68 $3.20 $3.72 $4.24 $4.76 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.09
High
$4.28
Low
$3.94
Volume
$2M
Avg Vol
$737,245
Mkt Cap
$161M
P/E (TTM)
Beta
52w High
$5.05
52w Low
$1.62
Div Yield
Shares Out
$33M

Overview

52-week range
$1.62
$5.05
73% of range
Avg surprise (last 1)
+20.0%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
205%
EM ±28.4% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.74$-0.56$-0.39$-0.22$-0.04 Actual $-0.12Actual $-0.07Actual $-0.74Actual $-0.34Actual $-0.04Est $-0.05 JunSepMarMar/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-18M$-13M$-8M$-4M$1M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.04 $-0.05 +20.0% +88.2% +2.2% earnings
Thu May 15, 2025Mar/2025 $-0.34 +5.7% earnings
Sun Mar 31, 2024Mar 2024 $-0.74 financials
Sat Sep 30, 2023Sep 2023 $-0.07 financials
Fri Jun 30, 2023Jun 2023 $-0.12 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$1M$242,000$0$0
Cost of revenue$631,000$97,000$0$0
Gross profit
Operating income$-5M$-4M$-4M$-4M$-3M$-7M
Net income$-1M$-6M$-18M$-6M$-2M$-8M
EPS (diluted)

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$7M$8M$7M$3M$6M$1M$2M$2M
Inventory
Total current assets$7M$9M$12M$5M$7M$3M$4M$5M
Total assets$12M$13M$15M$5M$8M$4M$4M$5M
Long-term debt
Total liabilities$26M$29M$41M$40M$33M$27M$23M$24M
Total equity$-14M$-16M$-26M$-36M$-25M$-23M$-19M$-18M

Implied volatility — last 90 days

199%202%204%207%209% Jun 07 — IV 205% · EM ±28.4%

Sector peers